Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03840486 · ClinicalTrials.gov registry record · Phase 4
Pre-oxygenation With Real Time End-tidal Oxygen Measurements Versus Single Breath Measurements
A Phase 4 study of Rapid Sequence Intubation, sponsored by Emory University.
- Completed
- Registry status
- Phase 4
- Development phase
- 105
- Enrollment target
- 2
- Study locations
NCT03840486 is a Phase 4 study of Rapid Sequence Intubation that has completed, run by Emory University. The registered enrollment target is 105 participants. The trial reports 2 study locations across 1 state.
The verdict
NCT03840486, a Phase 4 study of Rapid Sequence Intubation, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 105 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study examines the performance of a nasal cannula end-tidal oxygen (EtO2) measurement as compared to the gold standard of single breath end-tidal oxygen measurements in healthy volunteers. The purpose of this study is to examine the ability of each sensor to predict oxygen levels in real time.
Conditions Studied
Interventions
- DEVICE Non-rebreather mask (NRBM)
- DEVICE Non-invasive ventilator mask (NIV)
- DEVICE Nasal cannula EtO2 sensor
- DRUG Oxygen (NRBM)
- DRUG Oxygen (NIV)
Study Locations (2)
Georgia
- Grady Memorial Hospital - Atlanta
- Emory University Hospital Midtown - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 105 participants |
| Start Date | 2019-09-24 |
| Est. Completion | 2023-10-20 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03840486
The ClinicalTrials.gov registry entry for NCT03840486 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 105 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Rapid Sequence Intubation appearing as the primary indexed condition, and to 5 interventions - of which Non-rebreather mask (NRBM) is the first listed.
NCT03840486 reports 2 study locations spanning 1 distinct geographic area - top geographies include Georgia.
Frequently Asked Questions
What is clinical trial NCT03840486 about?
NCT03840486 is a clinical study titled "Pre-oxygenation With Real Time End-tidal Oxygen Measurements Versus Single Breath Measurements". This study examines the performance of a nasal cannula end-tidal oxygen (EtO2) measurement as compared to the gold standard of single breath end-tidal oxygen measurements in healthy volunteers. The purpose of this study is to examine the ability of each sensor to predict oxygen levels in real time.
What is the current status of trial NCT03840486?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 105 participants. The study started on 2019-09-24. Estimated completion is 2023-10-20.
What conditions does trial NCT03840486 study?
This clinical trial studies the following conditions: Rapid Sequence Intubation.
What interventions are being tested in trial NCT03840486?
The interventions under investigation include: Non-rebreather mask (NRBM) (DEVICE), Non-invasive ventilator mask (NIV) (DEVICE), Nasal cannula EtO2 sensor (DEVICE), Oxygen (NRBM) (DRUG), Oxygen (NIV) (DRUG).
Who is sponsoring clinical trial NCT03840486?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03840486 being conducted?
This trial has 2 study locations across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.